Fairport, NY, United States of America

Jamie O'Brien

This inventor holds 1 USPTO granted patent. Top assignee: University of Rochester. Active years: 2015.


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jamie O'Brien: Innovator in Platelet Production

Introduction

Jamie O'Brien is a notable inventor based in Fairport, NY (US). She has made significant contributions to the field of medical science, particularly in the area of platelet production and function. Her innovative work has the potential to impact treatments for patients with low platelet levels.

Latest Patents

Jamie O'Brien holds a patent for the "Use of electrophilic compounds for inducing platelet production or maintaining platelet function." This invention is directed to a method of inducing platelet production by contacting a megakaryocyte with an electrophilic compound under effective conditions. The patent also discloses methods for treating patients with low platelet levels, increasing the circulating half-life of platelets, and improving platelet quality. Pharmaceutical compositions and therapeutic systems are included to facilitate these treatments. She has 1 patent to her name.

Career Highlights

Jamie O'Brien is affiliated with the University of Rochester, where she continues her research and development in the medical field. Her work is characterized by a commitment to advancing healthcare solutions through innovative approaches.

Collaborations

One of her notable collaborators is Richard P. Phipps, with whom she has worked closely on various projects related to her patent.

Conclusion

Jamie O'Brien's contributions to the field of platelet production exemplify the impact of innovation in medical science. Her work not only advances research but also holds promise for improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…